Tagrid Antifungal Ringworm Treatment 1% CLOTRIMAZOLE

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Tagrid Antifungal Ringworm Treatment 1% CLOTRIMAZOLE
Generic name
CLOTRIMAZOLE
Manufacturer
TAGRID LLC
Product type
HUMAN OTC DRUG
SPL set ID
34af91bb-e04b-d252-e063-6294a90aaf96
SPL ID
0cf50f09-ecf4-4efd-b0e7-e3a15eb60d8c
Version
5
Effective date
2025-05-20
Source export date
2026-11-13
Source partition
12
Source file
https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/df974ce21ba33b4471866e2af5412327fbd4bcd68d14b42d7cfb3aa15d163738/drug-label-0012-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 17:54:43
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. Do not use: On irritated skin or any area that is infected or reddened If allergic to any of the ingredients. If pregnant or breastfeeding, unless directed by a doctor. Avoid contact with eyes Stop use and ask a doctor if: discomfort, burning, or irritation occurs lf no improvement within 4 weeks Do not use: If pregnant or breastfeeding, unless directed by a doctor. Keep out of reach of children. If product gets intoeyes,flush with water for 15 minutes. If swallowed, get medical help or contact a Poison Control Center immediately

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.